Pharma company Amarin's lawsuit claiming that an FDA decision violates its First Amendment right of free speech is simply an effort to circumvent the US drug approval process.
Erika Kelton, Contributor, Forbes
Thu, 05/28/2015 - 12:46pm
Pharma company Amarin's lawsuit claiming that an FDA decision violates its First Amendment right of free speech is simply an effort to circumvent the US drug approval process.